|
Financial Post
|
7
|
Resverlogix Corp.
|
Jan 19, 2022 01:38AM
|
|
Filings extension
|
2
|
Zenith Epigenetics
|
Aug 26, 2020 06:07PM
|
|
Exempt Distribution
|
8
|
Resverlogix Corp.
|
Feb 17, 2021 02:42PM
|
|
Exempt Distribution
|
8
|
Zenith Epigenetics
|
Feb 17, 2021 02:51PM
|
|
Exempt Distribution
|
6
|
Zenith Epigenetics
|
Aug 03, 2021 10:13PM
|
|
Exempt Distribution
|
7
|
Resverlogix Corp.
|
Sep 16, 2020 12:53AM
|
|
Exempt Distribution
|
3
|
Resverlogix Corp.
|
Mar 06, 2019 12:02AM
|
|
Exempt Distribution
|
5
|
Zenith Epigenetics
|
Mar 15, 2020 12:34AM
|
|
Exempt Dist.
|
6
|
Zenith Epigenetics
|
Apr 15, 2021 12:19AM
|
|
Est. Cash Position
|
4
|
Zenith Epigenetics
|
Apr 26, 2021 06:31PM
|
|
Early Warning Report
|
7
|
Zenith Epigenetics
|
Nov 12, 2020 07:32PM
|
|
Debt
|
7
|
Zenith Epigenetics
|
Apr 02, 2022 01:01PM
|
|
Debenture
|
4
|
Resverlogix Corp.
|
Sep 27, 2019 09:25PM
|
|
CRA
|
2
|
Resverlogix Corp.
|
Nov 15, 2019 04:38PM
|
|
Convertible Debenture
|
5
|
Zenith Epigenetics
|
May 15, 2020 01:34PM
|
|
Compensation
|
6
|
Resverlogix Corp.
|
May 21, 2022 01:13PM
|
|
clinicaltrials.gov
|
6
|
Resverlogix Corp.
|
May 15, 2021 03:04PM
|
|
CEO Pay
|
14
|
Resverlogix Corp.
|
Mar 31, 2022 02:33PM
|
|
CASH
|
8
|
Resverlogix Corp.
|
Oct 04, 2019 11:19PM
|
|
Cash
|
7
|
Zenith Epigenetics
|
Oct 05, 2019 10:46PM
|
